Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × OTHER × Osteosarcoma × Clear all

Phase

Status

Completed 101 Recruiting 62 Unknown 38 Active not recruiting 27 Terminated 25 Not yet recruiting 14 Withdrawn 9 Available 2 Suspended 1 Approved for marketing 1

Sponsor Class

NIH 2 OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 31 Neoplasms 27 Colorectal Neoplasms 19 Prostatic Neoplasms 18 Leukemia, Myeloid, Acute 13 Lung Neoplasms 11 Glioblastoma 11 Stomach Neoplasms 10 Head and Neck Neoplasms 9 Carcinoma, Non-Small-Cell Lung 9 Brain Neoplasms 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Pancreatic Neoplasms 8 Ovarian Neoplasms 8 Glioma 8 Melanoma 7 Carcinoma, Hepatocellular 7 Hematologic Neoplasms 6 Triple Negative Breast Neoplasms 5 Rectal Neoplasms 5 Polycystic Ovary Syndrome 5 Myelodysplastic Syndromes 5 Multiple Myeloma 5 Esophageal Neoplasms 5 Uterine Cervical Neoplasms 4 Neoplasm Metastasis 4 Lymphoma, B-Cell 4 Lymphoma 4 Leukemia 4 Colonic Neoplasms 4

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04824352 2024-05-14

AIEO

Peking University People's Hospital

Phase 2 Suspended

Osteosarcoma, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon ⚡